ViroGates A/S
CPH: VIRO.CO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Copenhagen
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Jakob Ole Knudsen
- Employees
- 7
- Headquarters
- Birkerød, Denmark
- IPO year
- 2018
- Market cap
- DKK 78.9M
- Website
- https://www.virogates.com
Loading VIRO…
Loading profile data…Frequently asked questions about VIRO
What does ViroGates A/S (VIRO.CO) do?
ViroGates A/S develops and markets prognostic products for the healthcare sector. It offers suPARnostic, a blood test that measures the soluble urokinase plasminogen activator receptor (suPAR) protein in the bloodstream used for emergency departments in hospitals to improve clinical decisions on hospitalization or discharge of acute medical pati...
Where does VIRO.CO trade?
ViroGates A/S (VIRO.CO) trades on the NASDAQ Copenhagen.
What sector is VIRO.CO in?
ViroGates A/S (VIRO.CO) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of ViroGates A/S?
Jakob Ole Knudsen is the chief executive officer of ViroGates A/S (VIRO.CO).
Where is ViroGates A/S headquartered?
ViroGates A/S is headquartered in Denmark.
Does VIRO.CO pay a dividend?
ViroGates A/S (VIRO.CO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VIRO.CO go public?
ViroGates A/S (VIRO.CO) completed its initial public offering in 2018.